Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Black Diamond Therapeutics, Inc. has good growth characteristics. Black Diamond Therapeutics, Inc. is not very popular among insiders. Black Diamond Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
BDTX Fundamental Data by TradingView

News

Wedbush Reiterates Outperform Rating for Black Diamond Therapeutics (NASDAQ:BDTX)
Wedbush Reiterates Outperform Rating for Black Diamond Therapeutics (NASDAQ:BDTX)

Zolmax Black Diamond Therapeutics (NASDAQ:BDTX - Get Free Report)s stock had its "outperform" rating reaffirmed by investment analysts at Wedbush in a research note issued on Tuesday, Benzinga...\n more…

Brokers Set Expectations for Black Diamond Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:BDTX)
Brokers Set Expectations for Black Diamond Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:BDTX)

Ticker Report Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - Equities researchers at HC Wainwright raised their Q3 2024 EPS estimates for shares of Black Diamond Therapeutics in a research note...\n more…

Black Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Reaffirmed by HC Wainwright
Black Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Reaffirmed by HC Wainwright

Zolmax Black Diamond Therapeutics (NASDAQ:BDTX - Get Free Report)s stock had its "buy" rating reiterated by research analysts at HC Wainwright in a report released on Wednesday, Benzinga reports...\n more…

SG Americas Securities LLC Invests $108,000 in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)
SG Americas Securities LLC Invests $108,000 in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)

Ticker Report SG Americas Securities LLC purchased a new stake in shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F...\n more…

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decrease in Short Interest
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decrease in Short Interest

Ticker Report Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling...\n more…

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Significant Drop in Short Interest
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Significant Drop in Short Interest

Zolmax Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totalling...\n more…